Literature DB >> 9279386

Characterization of mouse cellular deoxyribonucleic acid homologous to Abelson murine leukemia virus-specific sequences.

B Dale1, B Ozanne.   

Abstract

The genome of Abelson murine leukemia virus (A-MuLV) consists of sequences derived from both BALB/c mouse deoxyribonucleic acid and the genome of Moloney murine leukemia virus. Using deoxyribonucleic acid linear intermediates as a source of retroviral deoxyribonucleic acid, we isolated a recombinant plasmid which contained 1.9 kilobases of the 3.5-kilobase mouse-derived sequences found in A-MuLV (A-MuLV-specific sequences). We used this clone, designated pSA-17, as a probe restriction enzyme and Southern blot analyses to examine the arrangement of homologous sequences in BALB/c deoxyribonucleic acid (endogenous Abelson sequences). The endogenous Abelson sequences within the mouse genome were interrupted by noncoding regions, suggesting that a rearrangement of the cell sequences was required to produce the sequence found in the virus. Endogenous Abelson sequences were arranged similarly in mice that were susceptible to A-MuLV tumors and in mice that were resistant to A-MuLV tumors. An examination of three BALB/c plasmacytomas and a BALB/c early B-cell tumor likewise revealed no alteration in the arrangement of the endogenous Abelson sequences. Homology to pSA-17 was also observed in deoxyribonucleic acids prepared from rat, hamster, chicken, and human cells. An isolate of A-MuLV which encoded a 160,000-dalton transforming protein (P160) contained 700 more base pairs of mouse sequences than the standard A-MuLV isolate, which encoded a 120,000-dalton transforming protein (P120).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 9279386      PMCID: PMC369353          DOI: 10.1128/mcb.1.8.731-742.1981

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

1.  Lymphosarcoma: virus-induced thymic-independent disease in mice.

Authors:  H T Abelson; L S Rabstein
Journal:  Cancer Res       Date:  1970-08       Impact factor: 12.701

2.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

Review 3.  Virus leukemia in the mouse.

Authors:  M A Rich; R Siegler
Journal:  Annu Rev Microbiol       Date:  1967       Impact factor: 15.500

4.  Calcium-dependent bacteriophage DNA infection.

Authors:  M Mandel; A Higa
Journal:  J Mol Biol       Date:  1970-10-14       Impact factor: 5.469

5.  Influence of prednisolone on Moloney leukemogenic virus in BALB-c mice.

Authors:  H T Abelson; L S Rabstein
Journal:  Cancer Res       Date:  1970-08       Impact factor: 12.701

6.  Three new types of viral oncogenes in defective avian leukemia viruses. II. Biological, genetic, and immunochemical evidence.

Authors:  T Graf; H Beug; A von Kirchbach; M J Hayman
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1980

7.  Three new types of viral oncogenes in defective avian leukemia viruses. I. Specific nucleotide sequences of cellular origin correlate with specific transformation.

Authors:  D Stéhelin; S Saule; M Roussel; A Sergeant; C Lagrou; C Rommens; M B Raes
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1980

8.  Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA.

Authors:  S P Goff; E Gilboa; O N Witte; D Baltimore
Journal:  Cell       Date:  1980-12       Impact factor: 41.582

9.  Expression of unselected adenovirus genes in human cells co-transformed with the HSV-1 tk gene and adenovirus 2 DNA.

Authors:  T Grodzicker; D F Klessig
Journal:  Cell       Date:  1980-09       Impact factor: 41.582

10.  Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells.

Authors:  J L Jainchill; S A Aaronson; G J Todaro
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

View more
  10 in total

1.  Evidence for genetic heterogeneity in tuberous sclerosis.

Authors:  J R Sampson; J R Yates; L A Pirrit; P Fleury; I Winship; P Beighton; J M Connor
Journal:  J Med Genet       Date:  1989-08       Impact factor: 6.318

2.  Linkage of the tuberous sclerosis locus to a DNA polymorphism detected by v-abl.

Authors:  J M Connor; L A Pirrit; J R Yates; A E Fryer; M A Ferguson-Smith
Journal:  J Med Genet       Date:  1987-09       Impact factor: 6.318

3.  Cell transformation and tumor induction by Abelson murine leukemia virus in the absence of helper virus.

Authors:  P L Green; D A Kaehler; R Risser
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

4.  Clonal dominance and progression in Abelson murine leukemia virus lymphomagenesis.

Authors:  P L Green; D A Kaehler; R Risser
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

5.  Loss of viral gene expression and retention of tumorigenicity by Abelson lymphoma cells.

Authors:  D J Grunwald; B Dale; J Dudley; W Lamph; B Sugden; B Ozanne; R Risser
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

6.  Characterization of reticuloendotheliosis virus strain T DNA and isolation of a novel variant of reticuloendotheliosis virus strain T by molecular cloning.

Authors:  I S Chen; T W Mak; J J O'Rear; H M Temin
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

7.  Thymic targets for Abelson murine leukemia virus are early gamma/delta T lymphocytes.

Authors:  G D Holland; K Ito; D A Kaehler; S Tonegawa; R Risser
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

8.  Amplification and novel locations of endogenous mouse mammary tumor virus genomes in mouse T-cell lymphomas.

Authors:  J Dudley; R Risser
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

9.  Site-directed deletions of Abelson murine leukemia virus define 3' sequences essential for transformation and lethality.

Authors:  S M Watanabe; O N Witte
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

10.  Three different activated ras genes in mouse tumours; evidence for oncogene activation during progression of a mouse lymphoma.

Authors:  K H Vousden; C J Marshall
Journal:  EMBO J       Date:  1984-04       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.